Tag: nasal drug delivery
Zeteo Biomedical LLC Introduces OrionMRQ Nasal Delivery Device for Drugs and Vaccines
eNewsChannels NEWS: -- Zeteo Biomedical LLC announced today the availability of the ZEOx1 OrionMRQ™ nasal drug and vaccine delivery device. Zeteo's latest innovative delivery device provides pharmaceutical and biotech companies developing drugs, peptides, proteins, monoclonal antibodies and vaccines with precise, metered unit dose systemic delivery via the nasal route.
Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID-19 Vaccine Under Fast Track CARES Act
eNewsChannels NEWS: -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2 Delivery Platform.
